Literature DB >> 23782302

The CTLA-4 and MCP-1 polymorphisms and susceptibility to systemic sclerosis: a meta-analysis.

Gwan Gyu Song1, Young Ho Lee.   

Abstract

OBJECTIVE: The aim of this study was to explore whether cytotoxic T lymphocyte antigen-4 (CTLA-4) and monocyte chemoattractant protein-1 (MCP-1) polymorphisms confer susceptibility to systemic sclerosis (SSc).
METHODS: MEDLINE and manual search were utilized to identify available articles. A meta-analysis was conducted on the associations between the CTLA-4 +49 A/G, -318 C/T, -1661 A/G, and -1722 C/T, and MCP-1 -2518 A/G polymorphisms, using a fixed-effect or random-effect model based on between-study heterogeneity.
RESULTS: Eleven comparative studies involving 959 SSc patients and 1739 controls were included in the meta-analysis. No association was found between SSc and the CTLA-4 +49 A/G polymorphism (OR for the +49 G allele = 1.032, 95% CI = 0.830-1.283, p = 0.779). However, an association between SSc and the CTLA-4 -318 TT + TC genotype (OR = 1.642, 95% CI = 1.034-2.609, p = 0.036). Meta-analyses failed to reveal an association between SSc and CTLA-4 -1722 C/T, MCP-1 -2518 A/G polymorphisms.
CONCLUSIONS: This meta-analysis of published data shows that the CTLA-4 -318 C/T polymorphism confers susceptibility to SSc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23782302     DOI: 10.3109/08820139.2013.789910

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  5 in total

1.  The CC chemokine ligand 2 (CCL2) polymorphism -2518A/G is associated with gout in the Chinese Han male population.

Authors:  Ruixia Sun; Keke Zhang; Xiaokun Zhang; Lingling Cui; Can Wang; Qingsheng Mi; Shiguo Liu; Changgui Li
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

2.  Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.

Authors:  Mahdi Mahmoudi; Faranak Fallahian; Soheila Sobhani; Shima Ghoroghi; Ahmadreza Jamshidi; Shiva Poursani; Masoumeh Dolati; Zahra Hosseinpour; Farhad Gharibdoost
Journal:  Clin Rheumatol       Date:  2017-01-24       Impact factor: 2.980

Review 3.  Immunogenetics of autoimmune thyroid diseases: A comprehensive review.

Authors:  Hanna J Lee; Cheuk Wun Li; Sara Salehi Hammerstad; Mihaela Stefan; Yaron Tomer
Journal:  J Autoimmun       Date:  2015-07-30       Impact factor: 7.094

Review 4.  Targeting Costimulatory Pathways in Systemic Sclerosis.

Authors:  Gonçalo Boleto; Yannick Allanore; Jérôme Avouac
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

Review 5.  Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).

Authors:  Padmini Khedoe; Emiel Marges; Pieter Hiemstra; Maarten Ninaber; Miranda Geelhoed
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.